Genetic Screening IVF in Cyprus PGT Method and Scientific Approach
Genetic screening IVF (PGT - Preimplantation Genetic Testing) is the process of screening embryos for chromosomal abnormalities and single gene diseases before transfer to the uterus, selecting only the healthy ones.
Cyprus stands out with its advanced technological infrastructure and genetic screening methods in assisted reproductive treatments.
Advanced Genetic Methods Applied
- PGT-A (Aneuploidy Screening): A widely used method to screen for excess or deficiency in the number of embryo chromosomes (Down syndrome, etc.) and prevent pregnancies with sex chromosome-related abnormalities.
- PGT-M (Monogenic/Single Gene): Detects whether single gene diseases known in the family (thalassemia, cystic fibrosis, etc.) are present in the embryo.
- NGS (Next Generation Sequencing): With next-generation sequencing technology, all chromosomes are scanned in much greater detail with higher precision.
Who Is Genetic Screening Recommended For?
• Prospective mothers aged 35 and over with advanced maternal age • Couples with recurrent IVF failure or history of consecutive miscarriages • Presence of numerical or structural chromosomal abnormalities (translocation, etc.) in one of the partners • Families who wish to prevent the transmission of a known genetic disease to future generations
Medical Data: The transfer of healthy embryos selected through genetic screening (NGS) method significantly increases pregnancy rates while minimizing clinical miscarriage rates.
